JPS61126052A - Fluorine-containing methacrylic acid ester - Google Patents
Fluorine-containing methacrylic acid esterInfo
- Publication number
- JPS61126052A JPS61126052A JP24643984A JP24643984A JPS61126052A JP S61126052 A JPS61126052 A JP S61126052A JP 24643984 A JP24643984 A JP 24643984A JP 24643984 A JP24643984 A JP 24643984A JP S61126052 A JPS61126052 A JP S61126052A
- Authority
- JP
- Japan
- Prior art keywords
- fluorine
- formula
- methacrylic acid
- acid ester
- oxygen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Polyethers (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Eyeglasses (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
〔利用分野〕
本発明は酸素透過性を有するフッ素含有ポリマーの製造
用原料として有用な含フツ素メタクリル酸エステルに関
する。DETAILED DESCRIPTION OF THE INVENTION [Field of Application] The present invention relates to a fluorine-containing methacrylic acid ester useful as a raw material for producing a fluorine-containing polymer having oxygen permeability.
生物組織に対して継続的に酸素を付与したい場合に、物
理的攪拌などを伴う酸素負荷に対して不安定な生物学的
液体(例、血液)によらずに、酸素の付与が可能な酸素
透過体を用いることが好ましいが、本発明はかかる酵素
透過体製造用ポリマー製造用原料として有用な含フツ素
メタクリル酸エステルに関する。Oxygen that can be used to continuously supply oxygen to biological tissues without using biological fluids (e.g. blood) that are unstable to oxygen loading that requires physical agitation etc. Although it is preferable to use a permeable body, the present invention relates to a fluorine-containing methacrylic ester useful as a raw material for producing a polymer for producing such an enzyme permeable body.
さらに詳しくは、ハードコンタクトレンズ(HCL)の
ような眼科材料などの酸素透過体の製造原料として有用
な酸素透過性を有するフッ素含有ポリマー製造用の原料
として有用な含フツ素メタクリル酸エステルに関する。More specifically, the present invention relates to a fluorine-containing methacrylic acid ester useful as a raw material for producing a fluorine-containing polymer having oxygen permeability useful as a raw material for producing oxygen permeable materials such as ophthalmic materials such as hard contact lenses (HCL).
従来、HCL等の材料としては、ポリメチルメタフリレ
ー) (PMMA)がその優れた光学的性質、化学的性
質、物理的強度、機械的加工性のために広く利用されて
きた。Conventionally, polymethyl methane (PMMA) has been widely used as a material for HCL and the like due to its excellent optical properties, chemical properties, physical strength, and mechanical processability.
ところで、角膜は無血管組織であるから、その呼吸代謝
に必要な酸素は目を閉じている時は眼瞼粘膜の血管や房
水からの拡散により得られているが、眼を開いている時
は大気中から取り入れている。そのため、HCLを装着
することは酸素のバリヤーを形成することになり、充血
、浮腫およびその他の角111!害を生じることがある
。この角膜に必要な酸S!は3.5〜4.8 pJ (
STP ) /d、hrとされている。By the way, since the cornea is an avascular tissue, the oxygen necessary for its respiratory metabolism is obtained by diffusion from the blood vessels in the eyelid mucosa and the aqueous humor when the eyes are closed, but when the eyes are open. It is taken in from the atmosphere. Therefore, wearing HCL will form an oxygen barrier, leading to hyperemia, edema and other angles 111! May cause harm. Acid S necessary for this cornea! is 3.5 to 4.8 pJ (
STP) /d,hr.
従来のPMMA系HCLは、この酸素透過性が非常に小
さいため、HCLも小さいものしか装置できず、そのた
め目に対する異物感も大きく、酸素透過性の大きなHC
L等の酸素透過体の開発が望まれていた。そうした中で
近年、メタクリル酸エステルのエステル部分にンロキサ
ン結合を導入し、酸素透過性を向上させたノリコーンメ
タクリレート系HCL (特公昭52−33502)
、酢酪酸セルロース(CへB)を主体とした酸素透過性
OC+、、及びフッ素含有メタクリレートを使用した酸
素透過性HCL (特開昭57−51705)が開示さ
れている。Conventional PMMA-based HCL has very low oxygen permeability, so only small HCL devices can be used, which causes a strong foreign body sensation to the eyes.
It has been desired to develop an oxygen permeable material such as L. Under these circumstances, in recent years, noricone methacrylate-based HCL has been developed (Japanese Patent Publication No. 52-33502), which has improved oxygen permeability by introducing a nitrogen-loxane bond into the ester moiety of methacrylic acid ester.
, oxygen-permeable OC+ mainly composed of cellulose acetate butyrate (C to B), and oxygen-permeable HCL using fluorine-containing methacrylate (Japanese Patent Application Laid-Open No. 57-51705).
特公昭52−33502に開示されているシリコーンメ
タクリレート系HCLは、一般に従来のPMMA系HC
Lに比べて数十倍〜数百倍の酸素透過性を有しているが
、硬度や親水性に劣るので脂質等による汚れが付着しや
すいという欠点を存している。The silicone methacrylate-based HCL disclosed in Japanese Patent Publication No. 52-33502 is generally different from the conventional PMMA-based HC.
Although it has an oxygen permeability several tens to hundreds of times higher than that of L, it has the disadvantage that it is inferior in hardness and hydrophilicity, so it is easily contaminated with lipids and the like.
そのため、一般的には、メチルメタクリレート(MMA
)との共重合体の形をとるが、シリコーンメタクリレー
トの割合が多くなるとa!!素透素性過性上するが、上
記のような欠点が顕著になってくる。Therefore, methyl methacrylate (MMA
), but when the proportion of silicone methacrylate increases, a! ! However, the above-mentioned drawbacks become more noticeable.
また、ソフトコンタクトレンズも細菌や真菌による汚染
や涙液成分(タンパク質、脂質、ムチン等)による汚染
、取り扱いの煩雑なこと、煙草の煙やマスカラなど化粧
品によるt9染、黄変したり、白濁したりすること、寿
命の短いことなどの問題がある。In addition, soft contact lenses are also susceptible to contamination by bacteria and fungi, contamination by tear fluid components (proteins, lipids, mucin, etc.), cumbersome handling, T9 staining from cigarette smoke and cosmetics such as mascara, yellowing, and clouding. There are problems such as long life and short lifespan.
これに対し、フッ素含有ポリマーは耐食性があり、汚れ
に<<、酸素や二酸化炭素の透過性も大きく、この性質
を利用してフッ素含有モノマー〇共重合体から酸素透過
性の高いHCLを製造できることが既に見出されている
が、さらに酸素透過性、耐紫外線性、表面硬度、親水性
、防汚性の優れた、さらには眼等に装着した場合に異物
感のないHCLなどの医用酸素透過体、およびかかる酸
素透過体製造用のポリマーが待望されている。On the other hand, fluorine-containing polymers are corrosion resistant, resistant to stains, and highly permeable to oxygen and carbon dioxide.Using these properties, it is possible to produce HCL with high oxygen permeability from fluorine-containing monomer copolymers. Medical oxygen permeability, such as HCL, which has excellent oxygen permeability, ultraviolet resistance, surface hardness, hydrophilicity, and stain resistance, and does not give a foreign body feeling when worn on the eyes etc. There is a need for oxygen permeable bodies and polymers for producing such oxygen permeable bodies.
本発明の目的は、前記の如きすぐれた特性をもつ医用酸
素透過体製造用として有用な含フツ素ポリマーを製造す
るための原料車量体を提供することである。An object of the present invention is to provide a raw material polymer for producing a fluorine-containing polymer useful for producing a medical oxygen permeable material having the above-mentioned excellent properties.
C問題点を解決するための手段〕
本発明者らは、上記目的を達成するために、鋭意研究を
重ねて来た。その結果、一般式8式%
〔式中、A及びBばそれぞれ)、単原子又はペルフルオ
ロメチル基を、m及びnはそれぞれO又は1を、Xは一
般式
(但し、iは1〜8の整数を示す)
で表わされる基、又は一般式
(但し、D及びEはそれぞれフッ素原子又はペルフルオ
ロメチル基を、p及び「はそれぞれ1〜7の整数を、l
は前記と同意義)
で表わされる基を示す〕
で表わされる含フッ素メククリル酸エステルを創製し、
かつ、当該含フツ素メタクリル酸エステル(1)自体を
重合させるか、または好ましくは、当該含フツ素メタク
リル酸エステル(口と親水性上ツマ−、シリコン含有モ
ノマー、メククリル基含有七ツマ−ならびに重合可能な
官能基を2つ以上有する七ツマ−から選ばれる少なくと
も1つのモノマーとを用いて共重合させて調製されてな
る数平均分子量+000からROOOOの酸詣透過性を
有するフッ素含有ポリマーがら医用酸素透過体(就中、
HCL)を製造する時は、前述の目的が容易に達成され
ることを見い出し、本発明を完成するに至った。Means for Solving Problem C] The present inventors have conducted extensive research in order to achieve the above object. As a result, the general formula 8% [in the formula, A and B each represent a single atom or a perfluoromethyl group, m and n each represent O or 1, and X represents the general formula (however, i represents 1 to 8). (indicates an integer), or a group represented by the general formula (where D and E each represent a fluorine atom or a perfluoromethyl group, p and " each represent an integer from 1 to 7, and l
has the same meaning as above) indicates a group represented by]
And, the fluorine-containing methacrylic ester (1) itself is polymerized, or preferably, the fluorine-containing methacrylic ester (a hydrophilic monomer, a silicon-containing monomer, a meccrylic group-containing monomer, and a monomer containing a meccrylic group) is polymerized. Medical oxygen made from a fluorine-containing polymer having a number average molecular weight of +000 to ROOOO, which is prepared by copolymerizing with at least one monomer selected from the group consisting of seven monomers having two or more possible functional groups. Transparent bodies (especially
It has been found that the above object can be easily achieved when manufacturing HCL), and the present invention has been completed.
即ち、本発明は、新規含フツ素メタクリル酸エステル(
1)に関する。That is, the present invention provides a novel fluorine-containing methacrylic acid ester (
Regarding 1).
本明細書において、p及び「はそれぞれ1〜7の整数を
示すが、好ましくはpと「との和が2〜lOである。In this specification, p and " each represent an integer of 1 to 7, but preferably the sum of p and " is 2 to 1O.
本発明の含フツ素メタクリル酸エステル(1)本発明の
含フツ素メタクリル酸エステル(1)は、たとえば次の
ようにして製造される。テトラフルオロエチレンオキサ
イドやヘキサフルオロプロピレンオキサイドは、ジベル
フルオロアンルフルオロライド、例えば、F CO(C
F 2 )n COF等とフッ棄アニオンの存在下、ペ
ルフルオロポリエーテル(11を生成するが、これをヨ
ウ化物(2)とし、アリルアセテートと反応させ、エポ
キシド基をもつ化合物(3)に導くことは周知の通りで
ある〔たとえば、J、 Org、 Chew、、 27
.3033 (1962) ) −(上記式中、A、
L3およびXはAil記と同!!渡)さらに、ジエボキ
シド(3)をやや適量のメタクリル酸の反応性誘導体、
たとえば、メタクリル酸ハライド([FII 、メタク
リル酸クロリド)あるいはエチレングリコールモノメタ
クリレートとアルカリ(例えば、水酸化ナトリウム、水
酸化カリウム、トリエチルアミンなど)で処理すると、
目的とする含フツ素メタクリル酸エステル(T)が得ら
れる。Fluorine-containing methacrylic acid ester (1) of the present invention The fluorine-containing methacrylic acid ester (1) of the present invention is produced, for example, as follows. Tetrafluoroethylene oxide and hexafluoropropylene oxide are diberfluoroanlufluoride, such as F CO (C
In the presence of F2)n COF, etc. and a fluorinated anion, perfluoropolyether (11) is produced, which is converted into an iodide (2) and reacted with allyl acetate to lead to a compound (3) having an epoxide group. is well known [for example, J. Org. Chew, 27
.. 3033 (1962) ) -(In the above formula, A,
L3 and X are the same as Ail! ! Furthermore, dieboxide (3) is mixed with a slightly appropriate amount of a reactive derivative of methacrylic acid,
For example, treatment with methacrylic halide ([FII, methacrylic chloride) or ethylene glycol monomethacrylate and alkali (e.g., sodium hydroxide, potassium hydroxide, triethylamine, etc.]
The desired fluorine-containing methacrylic acid ester (T) is obtained.
本発明含フツ素メタクリル酸エステル(+)は、それ自
体を重合させることにより、または、親水性七ツマ−、
シリコン含有モノマー、メタクリル基含有モノマー、な
らびに重合可能な官能基を2つ以上有するモノマーから
選ばれる少なくとも1つのモノマーを用いて、共重合さ
せることによってf11棄透過性を有するポリマーとす
ることが出来る。The fluorine-containing methacrylic acid ester (+) of the present invention can be produced by polymerizing itself, or by polymerizing the fluorine-containing methacrylate ester (+) or
By copolymerizing at least one monomer selected from a silicon-containing monomer, a methacrylic group-containing monomer, and a monomer having two or more polymerizable functional groups, a polymer having f11 anti-permeability can be obtained.
共重合に用いられる親水性七ツマ−としては、エチレン
グリコールモノメタクリレート、ジエチレングリコール
モノメタクリレート、トリエチレングリコールモノメタ
クリレート、グリセリンメタクリレート、2−ヒドロキ
シエチルメタクリレート、N−ビニルピロリドン、ある
いはジメチルアクリルアミド等が挙げられる。親水性七
ツマ−の導入により、得られるポリマーの8M、水性を
改善し、体液成分との相互作用を抑えることができる。Examples of the hydrophilic seven polymers used in the copolymerization include ethylene glycol monomethacrylate, diethylene glycol monomethacrylate, triethylene glycol monomethacrylate, glycerin methacrylate, 2-hydroxyethyl methacrylate, N-vinylpyrrolidone, and dimethylacrylamide. By introducing the hydrophilic hexamer, it is possible to improve the 8M aqueous properties of the obtained polymer and suppress the interaction with body fluid components.
即ち、溶血等を抑える。That is, it suppresses hemolysis and the like.
シリコン含有モノマーとしては、3−(メタクリルオキ
シ)プロピルトリメトキシシラン、3−(メタクリルオ
キシ)プロピルビス(トリメチルシロキシ)メチルシラ
ン、あるいは3−(メタクリルオキシ)プロビルジメト
キンメチルンラン等が挙げられる。Examples of the silicon-containing monomer include 3-(methacryloxy)propyltrimethoxysilane, 3-(methacryloxy)propylbis(trimethylsiloxy)methylsilane, and 3-(methacryloxy)propyldimethquinemethylsilane.
メタクリル基含有モノマーとしては、メチルメタクリレ
ート、エチルメタクリレート、あるいはベンジルメタク
リレート等が挙げられる。Examples of the methacrylic group-containing monomer include methyl methacrylate, ethyl methacrylate, and benzyl methacrylate.
重合可能な官能基を2つ以上有する七ツマ−としては、
エチレングリコールジメタクリレート、ジエチレングリ
コールジメタクリレート、トリエチレングリコールジメ
タクリレート、テトラエチレングリ:t−ルジメククリ
レート、アリルメタクリレート、ジアリルフタレート、
あるいはトリメチロールプロパントリメタクリレート等
が挙げられる。As a hexamer having two or more polymerizable functional groups,
Ethylene glycol dimethacrylate, diethylene glycol dimethacrylate, triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, allyl methacrylate, diallyl phthalate,
Alternatively, trimethylolpropane trimethacrylate and the like can be mentioned.
共重合化をする場合の各モノマーの混合比としては、含
フツ素メタクリル酸エステル(I)5〜60重量%、親
水性モノマー5〜10重置%、シリコン含をモノマー2
5〜55重量%、メタクリル基含育モノマー1〜10重
量%、重合可能な官能基を2つ以上有するモノマー0.
1〜5重量%の組み合わせが好適なものとして例示され
る。In the case of copolymerization, the mixing ratio of each monomer is 5 to 60% by weight of the fluorine-containing methacrylic ester (I), 5 to 10% by weight of the hydrophilic monomer, and 2 to 2% of the silicon-containing monomer.
5 to 55% by weight, 1 to 10% by weight of a methacrylic group-containing monomer, and 0.0% of a monomer having two or more polymerizable functional groups.
A preferred example is a combination of 1 to 5% by weight.
共重合の際に用いられる重合開始剤としては、ベンゾイ
ルペルオキシド、t−ブチルペルオキシド、アブビスイ
ソブチロニトリルあるいはアゾビスジメチルバレロニト
リル等のラジカル重合開始剤が例示される。Examples of the polymerization initiator used in copolymerization include radical polymerization initiators such as benzoyl peroxide, t-butyl peroxide, abisisobutyronitrile, and azobisdimethylvaleronitrile.
重合に際しては、例えば、ラジカル重合開始剤を上記重
合用単量体総量100重量%に対して、0.01〜1,
5重量%の割合で混合使用する。ドライアイス−アセト
ン浴にit titし、凍結させ、約1ssllFで数
分間脱気し、真空下で融解させ、jlび凍結して脱気す
るという操作を数回繰り返した後、真空下で、50〜1
10℃、12〜98時間、重合処理を数回行う、具体的
には、まず50℃で6時間、次いで70℃で8時間、さ
らに90℃で5時間、最後に減圧下(約1 mug)
110℃で3時間加熱することにより重合を行うことが
できる。During polymerization, for example, the radical polymerization initiator may be added in an amount of 0.01 to 1% by weight based on 100% by weight of the total amount of the monomers for polymerization.
They are mixed and used at a ratio of 5% by weight. After several repetitions of freezing in a dry ice-acetone bath, freezing, degassing at about 1 ssllF for several minutes, thawing under vacuum, freezing and degassing several times, ~1
Polymerization treatment was carried out several times at 10°C for 12 to 98 hours, specifically, first at 50°C for 6 hours, then at 70°C for 8 hours, further at 90°C for 5 hours, and finally under reduced pressure (approximately 1 mg).
Polymerization can be carried out by heating at 110° C. for 3 hours.
こうして得られるポリマーは、高度な架m構造を有して
おり、酸素透過性にも富む、このポリマーの性質として
は、分子量1000〜eoooo、酸素透過係数3〜8
0 X 10−” cc、cs/ c+J、sec4s
Hg、屈折率1.35〜1.52、ビッカース硬度魚4
〜25が示される。The polymer thus obtained has a highly cross-linked structure and is highly oxygen permeable.The properties of this polymer include a molecular weight of 1000 to eoooo and an oxygen permeability coefficient of 3 to 8.
0 x 10-” cc, cs/c+J, sec4s
Hg, refractive index 1.35-1.52, Vickers hardness 4
~25 are shown.
本発明の含フツ素メタクリル酸エステル(1)よりなる
ポリマーは、酸素透過性、親水性、ぬれ性に優れたポリ
マーであり、成形、機械的加工も容易である。The polymer made of the fluorine-containing methacrylic acid ester (1) of the present invention is a polymer with excellent oxygen permeability, hydrophilicity, and wettability, and is easily molded and mechanically processed.
当該ポリマーは、医用酸素透過体(たとえば、HLCな
どの眼科領域の酸素透過体)として有用である。The polymers are useful as medical oxygen permeators (eg, oxygen permeators in the ophthalmology field, such as HLC).
当該ポリマーからの医用酸素透過体、就中HLCの製造
は、公知の手段にて加工、成形することによって行われ
る。A medical oxygen permeable material, especially HLC, is produced from the polymer by processing and molding using known means.
参考例1
硬質ガラス製封管用試験管(20龍φX10cm)中に
、七ツマ−3(p+r=8>
1.5g、3−(メタクリルオキシ)プロピルビス(ト
リノチルンaキシ)メチルシラン0.6g、メチルメタ
クリレート1.5g、ベンジルメタクリレート014g
、アリルメタクリレート0.2g、アゾビスイソブチロ
ニトリル20+*gを入れ、充分混合させた後、ドライ
アイス−アセトン浴につけ、凍結させ、5分間真空ポン
プを用いて約1mm1gで脱気し、試験管内が真空の状
態で常温にもどし、融解させた。気泡が生じるが、再び
凍結し、5分間脱気した。この操作を5回繰り返した後
、真空下で溶封し、50℃で24時間、70℃で5VF
間、90℃で8時間加熱した。生成したポリマーを約l
mHg、約100℃で24時間減圧乾燥し、微黄色透明
な機材を得た。ヴイソカース硬度は1k12、酸素透過
係数は5 X 10 ” cc、cm/c+J、sec
、mmHgであった。この機材をHCLに加工した。Reference Example 1 In a hard glass sealed test tube (20 mm φ x 10 cm), 1.5 g of Nanatsuma-3 (p+r=8>), 0.6 g of 3-(methacryloxy)propylbis(trinotyloxy)methylsilane, and methyl Methacrylate 1.5g, benzyl methacrylate 014g
, 0.2 g of allyl methacrylate, and 20+*g of azobisisobutyronitrile were added, mixed thoroughly, placed in a dry ice-acetone bath, frozen, degassed using a vacuum pump for 5 minutes at approximately 1 mm/1 g, and tested. While the inside of the tube was under vacuum, it was returned to room temperature and melted. Bubbles formed, then refrozen and degassed for 5 minutes. After repeating this operation 5 times, it was melt-sealed under vacuum, heated to 50℃ for 24 hours, and then heated to 70℃ for 5VF.
The mixture was heated at 90° C. for 8 hours. Approximately 1 liter of the produced polymer
It was dried under reduced pressure at mHg and about 100° C. for 24 hours to obtain a slightly yellow transparent material. Visocas hardness is 1k12, oxygen permeability coefficient is 5 x 10” cc, cm/c+J, sec
, mmHg. This equipment was processed into HCL.
実a例1
七ツマ−1〔一般式(+1において、Xは4Cr21−
H。Example a 1 Seven Tsuma-1 [General formula (+1, X is 4Cr21-
H.
1−4、m=n=Q、A、 BはCF3)即ち、式で示
される化合物の合成:
下式で示される含フツ素エポキシド
10.89g (2(1mM) 、水酸化カリウム33
7mg (6,0mM)及びヒドロキノン40mgを〜
マグネチックスクーラ一温度針、窒素ガス導入管、セブ
クム及び還流冷却袋Wt(ジムロート)を備え、油浴に
より随時加熱できるようにした50m1の三頚フラスコ
に人−れ、窒素気流下、メタクリルaft8.6 g
(100+sM)を注射器を用いて滴下した0反応液を
3時間かけて100℃にまで加熱し、更に同温度で8時
間加熱した。冷後、濾過し、メタクリル酸カリを除去し
、濾液にクロロホルムを加えて熔かし、0.5N水酸化
ナトリウム水溶液で水層が着色しなくなるまで数回洗浄
した0次いで飽和食塩水で数回洗浄し、乾燥後、重合防
止剤を加えて溶媒を留去した。さらに真空ポンベでよ(
溶媒を留去した。得られた反応液は粘稠なかっ免液であ
り、これをフラッシュカラムクロマトグラフィーで精製
したものは、無色透明、粘調な液体であった。 10.
20 g(収率71.0%)。1-4, m=n=Q, A, B are CF3) That is, synthesis of a compound represented by the formula: 10.89 g of fluorine-containing epoxide represented by the following formula (2 (1 mM), potassium hydroxide 33
7mg (6,0mM) and 40mg of hydroquinone ~
A person was placed in a 50 ml three-necked flask equipped with a magnetic cooler, a temperature needle, a nitrogen gas inlet tube, a sevcum, and a reflux cooling bag Wt (Dimroth) that could be heated at any time in an oil bath, and was heated under a nitrogen stream with methacrylic aft 8. 6g
(100+sM) was added dropwise using a syringe, and the reaction solution was heated to 100° C. over 3 hours, and further heated at the same temperature for 8 hours. After cooling, it was filtered to remove potassium methacrylate, chloroform was added to the filtrate and dissolved, and the mixture was washed several times with 0.5N aqueous sodium hydroxide solution until the aqueous layer was no longer colored.Then, the mixture was washed several times with saturated saline solution. After washing and drying, a polymerization inhibitor was added and the solvent was distilled off. Also, use a vacuum pump (
The solvent was distilled off. The obtained reaction solution was a non-viscous liquid, and when purified by flash column chromatography, it was a colorless, transparent, and viscous liquid. 10.
20 g (yield 71.0%).
IR(film、 cs+−”) :3400 (0
11) 、 1730 (C諺0 ) 、 1590
(C−C)F−NMR(CCffi4/ CFCI13
. pp■):82 (CF3 、6F) 、 93〜
94 (OCF?、 4F) 。IR (film, cs+-”): 3400 (0
11), 1730 (C proverb 0), 1590
(C-C)F-NMR (CCffi4/CFCI13
.. pp ■): 82 (CF3, 6F), 93~
94 (OCF?, 4F).
105〜118 (CF2 、4F) 、 134
(CFo、 2F )MS (El、■/2):
実測値(M” 、 720.13)
計算値 C22H2408Fl(、ニア20.12+4
実施例2
モノマー2〔一般式(口において、Xは4cr2吋。105-118 (CF2, 4F), 134
(CFo, 2F) MS (El, ■/2): Actual value (M”, 720.13) Calculated value C22H2408Fl (, Near 20.12+4
Example 2 Monomer 2 [General formula (in the mouth, X is 4 cr 2 inches.
!−6、m=n=1))即ち、式
で示される化合物の合成:
エチレングリコールモノメタクリレート13.02g
(100a+M) 、)リエチルアミン0.35g
(35sM)及びヒドロキノン40mgを上記と同様
の装置にとり、窒素気流下、注射器を用いて下式で示さ
れる含フツ素エポキシド
12.93g (20mM)を滴下、次いで反応液を8
5℃まで徐々に加熱し、さらに同温度で一夜加熱した。! -6, m=n=1)) That is, synthesis of the compound represented by the formula: 13.02 g of ethylene glycol monomethacrylate
(100a+M),) ethylamine 0.35g
(35 sM) and 40 mg of hydroquinone were placed in the same apparatus as above, and under nitrogen flow, 12.93 g (20 mM) of fluorine-containing epoxide represented by the following formula was added dropwise using a syringe.
The mixture was gradually heated to 5°C and further heated at the same temperature overnight.
冷後、クロロホルム200+wlを加え、有機層を0.
5N水酸化ナトリウム水′f4/&で水層が着色しなく
なるまC数回、更に飽和食塩水で数回洗浄した。有機層
に重合防止剤を適量加え、無水硫酸マグネシウムで乾燥
後、溶媒を留去し、さらに減圧下(約l m+wHg)
溶媒を除去した。残渣をフラシュカラムクロマトグラフ
ィーで精製して、粘稠な微黄色の透明IIi、を得た。After cooling, chloroform 200+wl was added and the organic layer was reduced to 0.
The mixture was washed several times with 5N sodium hydroxide solution until the aqueous layer was no longer colored, and then several times with saturated brine. An appropriate amount of polymerization inhibitor was added to the organic layer, and after drying over anhydrous magnesium sulfate, the solvent was distilled off, and further under reduced pressure (approximately 1 m + wHg)
Solvent was removed. The residue was purified by flash column chromatography to obtain viscous, slightly yellow, transparent IIi.
このものはTLCでシングルスポットのみを与えた。1
1.94g(収率66.0%)、融点約15℃。This gave only a single spot on TLC. 1
1.94 g (yield 66.0%), melting point approximately 15°C.
IR(film、 (J−’) :
3350 (OH) 、 1745 (C−0) 、
1620 (C=C)F−NMR(CIJ4/ CPC
It3. ppm ) ニア5〜80 (CF3 )
、 90〜93 (CF20)105〜123 (C
F2 )
元素分析:
実験値 C; 38.42%、 F 、42.4%計
算値 C28H3oO工。F2o:C;37.08%H
;3.34%、 F 、41.93%実施例3
七ツマ−3〔一般式(1)において、A、B。IR (film, (J-'): 3350 (OH), 1745 (C-0),
1620 (C=C)F-NMR (CIJ4/CPC
It3. ppm) Near 5-80 (CF3)
, 90-93 (CF20) 105-123 (C
F2) Elemental analysis: Experimental value C; 38.42%, F, 42.4% calculated value C28H3oO engineering. F2o:C; 37.08%H
; 3.34%, F, 41.93% Example 3 Nanatsumer-3 [A, B in general formula (1).
D、 EはCF31!−5、p+r−81即ち、式で示
される化合物の合成:
次式で示される含フッ素エポキシド
+p+q璽8)
3.2 g (1,5sM) 、水酸化カリウム56…
g(約1mM)及びヒドロキノン(5mg)を実施例1
に記載と同様な反応容器にとり、メタクリル酸690m
g(約8mM)及びベンゼン20鋼!を加え15時間還
流した。実施例1と同様に処理し、わずかに黄味を帯び
た固体を2.4g得た。融点約50℃、lRではエポキ
シドの吸収を認めず、水酸基、カルボニル基の吸収なら
びに二重結合に基因する弱い吸収を認めた。D and E are CF31! -5, p+r-81, that is, synthesis of the compound represented by the formula: Fluorine-containing epoxide +p+q8) represented by the following formula 3.2 g (1.5 sM), potassium hydroxide 56...
Example 1
Into a reaction vessel similar to that described in , add 690 m of methacrylic acid.
g (approximately 8mM) and benzene 20 steel! was added and refluxed for 15 hours. It was treated in the same manner as in Example 1 to obtain 2.4 g of a slightly yellowish solid. At a melting point of about 50° C. and 1R, no absorption of epoxide was observed, but absorption of hydroxyl groups, carbonyl groups, and weak absorption due to double bonds was observed.
元素分析:
実験値 C;28.5%、F;57.0%計算値 (C
47H22016F56 ) C; 29.01%H;
1.14%、 F ;56.68 %手続ネili
正−3(自発)
昭和60年1月26日
昭和59年特許願第246439号
2、発明の名称
含フツ素メタクリル酸エステル
3、補正をする者
事件との関係 特許出願人
氏名(名称) 株式会社 ミドリ十字
4、代理人■541
住所 大阪市東区平野町4丁目53fk地3ニエーライ
フ平野町406号
Tht (06) 227−1158
6、補正の内容
分子量=720 モノマー1分子11
−866 モノマー2分子量−718
モノマー1
分子量=906 七ツマ−2(2)同
書第8頁、第1θ行の「27」をリュ」に訂正する。Elemental analysis: Experimental value C: 28.5%, F: 57.0% Calculated value (C
47H22016F56) C; 29.01%H;
1.14%, F; 56.68% procedure
Correct -3 (spontaneous) January 26, 1985 Patent Application No. 246439 of 1988 2, Title of invention Fluorine-containing methacrylic acid ester 3, Relationship with the person making the amendment Case Name of patent applicant Stocks Company Midori Juji 4, Agent 541 Address No. 406, Nie Life Hirano-cho, 4-53FK, Higashi-ku, Higashi-ku, Osaka Tht (06) 227-1158 6. Correction details Molecular weight = 720 Monomer 1 molecule 11
-866 Monomer 2 molecular weight -718
Monomer 1 Molecular weight = 906 Nanatsuma-2 (2) On page 8 of the same book, in line 1θ, "27" is corrected to "Ryu".
(3)同署第8頁の に訂正する。(3) On page 8 of the police station Correct to.
(4)間書第11頁、第19行の「ドラ」の前に「混合
物を」を加入する。(4) Add ``Mixture'' before ``Dora'' on page 11, line 19 of the interlude.
(5)同書第12頁、第4〜5行の「6時間」を「6〜
48時間」に訂正する。(5) On page 12 of the same book, lines 4-5, “6 hours” is replaced with “6-
Corrected to 48 hours.
(6)同書第12頁、第5行の「8時間」を「8〜24
時間」に訂正する。(6) On page 12 of the same book, line 5, “8 hours” was replaced with “8 to 24 hours.”
Correct to "Time".
(7)同署第12頁、第5〜6行の「5時間」を「5〜
12時間」に訂正する。(7) On page 12 of the police station, lines 5-6, “5 hours” is replaced with “5-5 hours”.
Corrected to ``12 hours''.
(8)同書第12頁、第6行の「3時間」を「3〜12
時間」に訂正する。(8) On page 12 of the same book, line 6, “3 hours” is replaced with “3 to 12 hours.”
Correct to "Time".
(9)同書第13頁の に訂正する。(9) Same book, page 13 Correct to.
(10)同書第15頁、第9行の「ボンベ」を「ポンプ
」に訂正する。(10) "Cylinder" in line 9 on page 15 of the same book is corrected to "pump."
(11)同書第17頁、第4行の「フランユヵラム」を
「フラッシュカラム」に訂正する。(11) On page 17 of the same book, line 4, "Franyu Kalam" is corrected to "Flash Column".
(12)同書第18真の式 %式% に訂正する。(12) The 18th true formula of the same book %formula% Correct to.
以上that's all
Claims (1)
ロメチル基を、m及びnはそれぞれ0又は1を、Xは一
般式 −(CF_2)−_l (但し、lは1〜8の整数を示す) で表わされる基、又は一般式 ▲数式、化学式、表等があります▼ (但し、D及びEはそれぞれフッ素原子又はペルフルオ
ロメチル基を、p及びrはそれぞれ1〜7の整数を、l
は前記と同意義) で表わされる基を示す〕 で表わされるフッ素含有メタクリル酸エステル。[Claims] General formula ▲ Numerical formula, chemical formula, table, etc. ▼ [In the formula, A and B each represent a fluorine atom or a perfluoromethyl group, m and n each represent 0 or 1, and X represents the general formula - (CF_2)-_l (where l is an integer from 1 to 8) or general formula ▲ Numerical formula, chemical formula, table, etc. ▼ (However, D and E are each a fluorine atom or a perfluoromethyl group) , p and r each represent an integer from 1 to 7, l
has the same meaning as above) represents a group represented by the following:] A fluorine-containing methacrylic acid ester represented by the following.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24643984A JPS61126052A (en) | 1984-11-20 | 1984-11-20 | Fluorine-containing methacrylic acid ester |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24643984A JPS61126052A (en) | 1984-11-20 | 1984-11-20 | Fluorine-containing methacrylic acid ester |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS61126052A true JPS61126052A (en) | 1986-06-13 |
Family
ID=17148477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP24643984A Withdrawn JPS61126052A (en) | 1984-11-20 | 1984-11-20 | Fluorine-containing methacrylic acid ester |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61126052A (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6399229A (en) * | 1986-08-29 | 1988-04-30 | チバ・ガイギ−・アクチェンゲゼルシャフト | Substantially non-swellable polymer containing polyoxyalkylene skeletal unit, contact lens prepared using the same and use thereof |
| JPH028218A (en) * | 1988-02-26 | 1990-01-11 | Ciba Geigy Ag | Wettable, flexible, oxygen-permeable and swellable polymer containing polyoxyalkylene skeletal unit and use thereof |
| US5155194A (en) * | 1988-12-19 | 1992-10-13 | Ciba-Geigy Corporation | Hydrogels based on fluorine-containing and saccharide monomers |
| US5214452A (en) * | 1988-12-19 | 1993-05-25 | Ciba-Geigy Corporation | Hydrogels based on fluorine-containing and saccharide monomers |
| JP2012072232A (en) * | 2010-09-28 | 2012-04-12 | Dic Corp | Polymerizable fluorine-based compound, active energy ray-curable composition using the same, and cured product of the composition |
| CN109963894A (en) * | 2017-01-26 | 2019-07-02 | 昭和电工株式会社 | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium |
| US11767483B2 (en) | 2018-09-12 | 2023-09-26 | Resonac Corporation | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium |
| US11820953B2 (en) | 2019-03-12 | 2023-11-21 | Resonac Corporation | Fluorine-containing ether compound, lubricant for magnetic recording medium and magnetic recording medium |
| US11879109B2 (en) | 2019-09-18 | 2024-01-23 | Resonac Corporation | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium |
| US11905365B2 (en) | 2019-12-26 | 2024-02-20 | Resonac Corporation | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium |
| US12100434B2 (en) | 2020-02-07 | 2024-09-24 | Resonac Corporation | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium |
| US12338407B2 (en) | 2019-11-07 | 2025-06-24 | Resonac Corporation | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium |
-
1984
- 1984-11-20 JP JP24643984A patent/JPS61126052A/en not_active Withdrawn
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6399229A (en) * | 1986-08-29 | 1988-04-30 | チバ・ガイギ−・アクチェンゲゼルシャフト | Substantially non-swellable polymer containing polyoxyalkylene skeletal unit, contact lens prepared using the same and use thereof |
| JPH028218A (en) * | 1988-02-26 | 1990-01-11 | Ciba Geigy Ag | Wettable, flexible, oxygen-permeable and swellable polymer containing polyoxyalkylene skeletal unit and use thereof |
| US5155194A (en) * | 1988-12-19 | 1992-10-13 | Ciba-Geigy Corporation | Hydrogels based on fluorine-containing and saccharide monomers |
| US5214452A (en) * | 1988-12-19 | 1993-05-25 | Ciba-Geigy Corporation | Hydrogels based on fluorine-containing and saccharide monomers |
| JP2012072232A (en) * | 2010-09-28 | 2012-04-12 | Dic Corp | Polymerizable fluorine-based compound, active energy ray-curable composition using the same, and cured product of the composition |
| US11220649B2 (en) | 2017-01-26 | 2022-01-11 | Showa Denko K.K. | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium |
| CN109963894A (en) * | 2017-01-26 | 2019-07-02 | 昭和电工株式会社 | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium |
| US11767483B2 (en) | 2018-09-12 | 2023-09-26 | Resonac Corporation | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium |
| US11820953B2 (en) | 2019-03-12 | 2023-11-21 | Resonac Corporation | Fluorine-containing ether compound, lubricant for magnetic recording medium and magnetic recording medium |
| US11879109B2 (en) | 2019-09-18 | 2024-01-23 | Resonac Corporation | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium |
| US12338407B2 (en) | 2019-11-07 | 2025-06-24 | Resonac Corporation | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium |
| US11905365B2 (en) | 2019-12-26 | 2024-02-20 | Resonac Corporation | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium |
| US12100434B2 (en) | 2020-02-07 | 2024-09-24 | Resonac Corporation | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2619245B2 (en) | Transparent polymer material for hydrogel contact lenses and optically transparent hydrophilic contact lens comprising the same | |
| US4436887A (en) | N-Vinyl lactam based biomedical devices | |
| US4139692A (en) | Copolymer for contact lens, its preparation and contact lens made thereof | |
| JPS61126052A (en) | Fluorine-containing methacrylic acid ester | |
| JPS59185310A (en) | Soft contact lens composition permeable to oxygen | |
| US5057585A (en) | Oxygen-permeable article of fluorinated hydrocarbon group-grafted (meth)acrylate polymers | |
| US5466853A (en) | Diester monomer, its polymer, water-containing soft contact lens, and processing solution for contact lens | |
| JP2019104923A (en) | Water-soluble silicone material | |
| JPS61123609A (en) | Fluorine-containing polymer and oxygen-permeable material for medical use | |
| JPS61111308A (en) | Fluorine-containing polymer and oxygen-permeable body for medical use | |
| Friends et al. | High‐strength hydrogels based on N‐vinyl pyrrolidinone and 4‐t‐butyl‐2‐hydroxycyclohexylmethacrylate | |
| JPS63210114A (en) | Oxygen-permeable material | |
| JPH02269306A (en) | Fluorine based contact lens | |
| JPS6173706A (en) | Fluorine-containing polymer and medical oxygen-permeable body | |
| JPH0312410A (en) | Fluorine-containing copolymer and contact lens made thereof | |
| JPH0813864B2 (en) | Oxygen permeators and contact lenses | |
| JPS6214860A (en) | Medical material | |
| JPS61112047A (en) | Fluorine-containing methacrylic acid ester | |
| JP2532151B2 (en) | Oxygen-permeable hard contact lens | |
| JP2019219620A (en) | Contact lens solution | |
| JPS61197609A (en) | Fluorine-containing polymer and medical oxygen-permeable body | |
| JPH04194816A (en) | High oxygen permeable contact lens | |
| JP2591154B2 (en) | contact lens | |
| JPS60173518A (en) | Preparation of hydrous contact lens | |
| JPS63168416A (en) | Oxygen-permeable body |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |